Lung Diseases

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.


100-year anniversary

In 1921, Boehringer Ingelheim set out with a vision to transform the world of respiratory care. 2021 marks the company looks back on 100 years of pushing the boundaries in scientific innovation.


Related Press Releases

Products A to Z

Human Health Products

A complete overview of our products for Human Health.